100 filings
Page 3 of 5
8-K
086y jq0l6d
1 Mar 21
Biohaven Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Developments
4:04pm
8-K
qb2rlcq vtktj1zfz
26 Jan 21
Biohaven Announces Preliminary 4Q2020 Net Product Revenue for Nurtec® Odt
7:04am
8-K
gv777 qkmb0y27
8 Jan 21
Biohaven Acquires Kleo Pharmaceuticals and Licenses Platform Technology from Yale University to Form Biohaven Labs
12:00am
8-K
op5jy
23 Dec 20
Other Events
4:12pm
8-K
vzmvs5eymp
9 Nov 20
Biohaven Reports Third Quarter 2020 Financial Results and Recent Business Developments
4:05pm
8-K
o8qpevvj8ah
18 Aug 20
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
3kpf3l 76j
10 Aug 20
Biohaven Reports Second Quarter 2020 Financial Results and Recent Business Developments
7:47am
8-K
0tg21nbvih ccrl18yp
12 Jun 20
Biohaven Appoints Bob Hugin to its Board of Directors
5:07pm
8-K
ieqzo5vnctr9 76m
2 Jun 20
Regulation FD Disclosure
9:02am
8-K
0s3o1u 4esusb6mbrkk
19 May 20
Regulation FD Disclosure
4:32pm
8-K
9xlghiw
7 May 20
Biohaven Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent Business Developments
5:09pm
8-K
pl261 u9fo19jf17yn
30 Apr 20
Submission of Matters to a Vote of Security Holders
5:25pm
8-K
7vuog3efsy
17 Apr 20
BIOHAVEN Changing 2020 Annual Meeting of Shareholders to Virtual-Only Meeting Format due to COVID-19
12:00am
8-K
gk0dy5vv
31 Mar 20
Biohaven Achieves Positive Results in Pivotal Trial of Oral NURTEC™, Dosed Every Other Day, for the Preventive Treatment of Migraine
5:11pm
8-K
4yfn npm5
4 Mar 20
Changes in Registrant's Certifying Accountant
5:03pm
8-K
1ssquix99amjxljma83
28 Feb 20
Biohaven’s Nurtec™ Odt (Rimegepant) Receives Fda Approval for the Acute Treatment of Migraine In Adults
12:00am
8-K
c5oe651
26 Feb 20
Biohaven Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Developments
12:00am
8-K
fwrbicui0v
31 Jan 20
BIOHAVEN APPOINTS Michael heffernan TO BOARD OF DIRECTORS
5:18pm
8-K
854y5pol60pue w03e
30 Jan 20
Other Events
4:27pm
8-K
syty ndm42f
13 Jan 20
Regulation FD Disclosure
6:54am